Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Cognition,Behavior,and the Rest-Activity Rhythm in Children with Attention Deficit Hyperactivity Disorder,Combined Type
Free accessResearch articleFirst published online December, 2004
Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Cognition,Behavior,and the Rest-Activity Rhythm in Children with Attention Deficit Hyperactivity Disorder,Combined Type
Objective. The aim of this study was to examine the effects of transcutaneous electrical nerve stimulation (TENS) on cognition, behavior, and the rest-activity rhythm in children with attention deficit hyperactivity disorder, combined type (ADHD-CT). Methods. Twenty-two children diagnosed with ADHD-CT received TENS treatment during 6 weeks, 2 times 30 min a day. Neuropsychological tests were administered to assess cognition, parent/teacher behavioral rating scales were used to measure behavior, and actigraphy was used to assess the rest-activity rhythm. Results. TENS appeared to have a moderate beneficial influence on cognitive functions that load particularly on executive function. There was also improvement in behavior as measured by parent/teacher behavioral rating scales. Moreover, motor restlessness during sleep and motor activity during the day decreased by TENS. Conclusions. The effects of TENS in children with ADHD are modest but encouraging and warrant further research.
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington, DC: American Psychiatric Association; 1994.
2.
2. American Psychiatric Association. Diagnostic and statisticalmanualofmentaldisorders (Text-Revision). 4th ed.Washington, DC: American Psychiatric Association; 2000.
3.
3. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet1998;351:429-433.
4.
4. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull1997;121:65-94.
5.
5. Mercugliano M. What is attention-deficit/hyperactivity disorder?Pediatr Clin North Am1999;46:831-843.
6.
6. Casey BJ, Castellanos FX, Giedd JN, et al. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1997;36:374-383.
8. Oosterlaan J, Sergeant JA. Response inhibition and response re-engagement in attention-deficit/hyperactivity disorder, disruptive, anxious and normal children. Behav Brain Res1998;94:33-43.
9.
9. Rubia K, Oosterlaan J, Sergeant JA, Brandeis D, Leeuwen T. Inhibitory dysfunction in hyperactive boys. Behav Brain Res1998;94:25-32.
10.
10. Sergeant JA, Oosterlaan J, van der Meere JJ. Information processing and energetic factors in attention-deficit/hyper-activity disorder. In: Quay HC, Hogan A, eds. Handbook of disruptive behavior disorders. New York: Plenum Press; 1999:75-104.
11.
11. Douglas VI. Cognitive control processes in attention-deficit/hyperactivity disorder. In: Quay HC, Hogan A, eds. Handbook of disruptive behavior disorders. New York:Plenum Press; 1999:105-138.
12.
12. Barkley RA. Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr1997;18:271-279.
13.
13. Denckla MB. Biological correlates of learning and attention: what is relevant to learning disability and attention-deficit hyperactivity disorder?J Dev Behav Pediatr1996;17:114-119.
14.
14. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed.New York: Guilford; 1998.
15.
15. Marcotte AC, Thacher PV, Butters M, Bortz J, Acebo C, Carskadon MA. Parental report of sleep problems in children with attentional and learning disorders. J Dev Behav Pediatr1998;19:178-186.
16.
16. Ring A, Stein D, Barak Y, et al. Sleep disturbances in children with attention deficit/hyperactivity disorder: a comparative study with healthy siblings. J Learn Disabil1998;31:572-578.
17.
17. American Psychiatric Association. Diagnostic and statisticalmanualofmentaldisorders. 3rd ed.Washington, DC: American Psychiatric Association; 1980.
18.
18. Porrino LJ, Rapoport JL, Behar D, et al. A naturalistic assessment of the motor activity of hyperactive boys: I. Comparison with normal controls. Arch Gen Psychiatry1983;40:681-687.
19.
19. Gruber R, Sadeh A, Raviv A. Instability of sleep patterns in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry2000;39:495-501.
20.
20. Thunström M. Severe sleep problems in infancy associated with subsequent development of attention-deficit/hyperactivity disorder at 5.5 years of age. Acta Paediatr2002;9:584-592.
21.
21. O’Brien LM, Ivanenko A, Crabtree VM, et al. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. Sleep Med2003;4:309-316.
22.
22. Sei H, Saitoh D, Yamamoto K, Morita K, Morita Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res2000;877:387-390.
23.
23. Sei H, Fujihara H, Ueta Y, Morita K, Kitahama K, Morita Y. Single eight-hour shift of light-dark cycle increases brain-derived neurotrophic factor protein levels in the rat hippo-campus. Life Sci2003;73:53-59.
25. Santosh PJ, Taylor E. Stimulant drugs. Eur Child Adolesc Psychiatry2000;9:127-143.
26.
26. Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J Clin Psychiatry1998;59:42-49.
27.
27. Garland EJ. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. J Psychopharmacol1998;12:385-395.
28.
28. Scherder EJA, Bouma A, Steen AM. Influence of transcutaneous electrical nerve stimulation on memory in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol1992;14:951-960.
29.
29. Scherder EJA, Bouma A, Steen AM. Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer’s disease. Behav Brain Res1995;67:211-219.
30.
30. Scherder EJA, Bouma A, Steen AM. ‘Isolated’ transcutaneous electrical nerve stimulation in Alzheimer’s disease. Biol Psychiatry1998;43:417-424.
31.
31. Scherder EJA, Van Someren EJW, Swaab DF. Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer’s disease. Behav Brain Res1999; 101:105-107.
32.
32. Scherder EJA, Van Someren EJW, Bouma A, van der Berg M. Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in ageing. Behav Brain Res2000;111:223-225.
34. Burstein R, Giesler GJ Jr. Retrograde labeling of neurons in spinal cord that project directly to nucleus accumbens or the septal nuclei in the rat. Brain Res1989;497:149-154.
35.
35. Burstein R, Cliffer KD, Giesler GJ Jr. Cells of origin of the spinohypothalamic tract in the rat. J Comp Neurol1990;291:329-344.
36.
36. Cliffer KD, Burstein R, Giesler GJ Jr. Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by anterograde transport of PHA-L in rats. J Neurosci1991; 11:852-868.
37.
37. Giesler GJ, Katter T, Dado RJ. Direct spinal pathways to the limbic system for nociceptive information. Trends Neurosci1994;17:244-250.
38.
38. Carpenter GA, Grossberg S. Normal and amnesic learning, recognition and memory by a neural model of corticohippocampal interactions. Trends Neurosci1993;16:131-137.
39.
39. Swaab DF. Neurobiology and neuropathology of the human hypothalamus. In: Bloom FE, Björklund A, Hökfelt T, eds. The primate nervous system: Part 1. Handbook of chemical neuroanatomy. vol. 13. Amsterdam: Elsevier; 1997:39-137.
40.
40. Swaab DF, Lucassen PJ, Salehi A, et al. Reduced neuronal activity and reactivation in Alzheimer’s disease. Prog Brain Res1998;117:343-377.
41.
41. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol1991;82:239-259.
42.
42. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry1992;55:967-972.
43.
43. Scherder EJ, Luijpen MW, van Dijk KR. Activation of the dorsal raphe nucleus coeruleus by transcutaneous electrical nerve stimulation in Alzheimer’s disease: a reconsideration of stimulation-parameters derived from animal studies. Chin J Physiol2003;46:143-150.
44.
44. Rossor M. Neurochemical studies in dementia. In: Iversen LL, Iversen SD, Snijder SH, ed. Handbook of psychopharmacology. New York: Plenum; 1988:107-130.
45.
45. Kayama Y, Koyama Y. Brainstem neural mechanisms of sleep and wakefulness. Eur Urol1998;33:12-15.
46.
46. Robbins TW, Everitt BJ. Arousal systems and attention. In: Gazzanigaet al., eds. The cognitive neurosciences. Cambridge, MA: MIT Press; 1995:703-720.
47.
47. Jonides J, Smith EE, Marshuetz C, Koeppe RA, Reuter-Lorenz PA. Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A1998;95:8410-8413.
48.
48. Rosenberg DR, Dick EL, O’Hearn KM, Sweeney JA. Response-inhibition deficits in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal circuits. J Psychiatr Neurosci1997;22:29-38.
49.
49. Strik WK, Fallgatter AJ, Brandeis D, Pascual-Marqui RD. Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation. Electroencephalogr Clin Neurophysiol1998;108:406-413.
50.
50. Pelham WE Jr, Gnagy EM, Greenslade KE, Milich R. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry1992;31:210-218.
51.
51. Oosterlaan J, Scheres A, Antrop I, Roeyers, H, Sergeant JA. Vragenlijst voor Gedragsproblemen bij Kinderen. Lisse: Swets & Zeitlinger; 2000.
52.
52. Wechsler D. Manual for the Wechsler Intelligence Scale for Children-Revised. New York: Psychological Corporation; 1974.
53.
53. Kaufman AS. Factor analysis of the WISC-R at eleven age levels between 6 12 and 16 12 years. J Consult Clin Psychol1975;43:135-147.
54.
54. Bourdon B, Wiersma ED. De Bourdon-Vos Test, voorheen de Bourdon-Wiersma Test. In: Kamphuis GH, ed., Een bijdrage tot de geschiedenis van de Bourdon Test. Ned Tijdschr Psychol 1962;12:247-68.
55.
55. Zeeuw De J. Algemene Psychodiagnostiek I. Testmethoden. Lisse: Swets & Zeitlinger; 1995.
58. Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol1978;6:221-236.
59.
59. Eriksson MB, Sjölund BH, Nielzen S. Long term results of peripheral conditioning stimulation as an analgesic measure in chronic pain. Pain1979;6:335-347.
60.
60. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.Hillsdale, NJ: Lawrence Erlbaum; 1988.
61.
61. Yang P, Chung LC, Chen CS, Chen CC. Rapid improvement in academic grades following methylphenidate treatment in attention-deficit hyperactivity disorder. Psychiatr Clin Neurosci2004;58:37-41.
62.
62. Markela-Lerenc J, Ille N, Kaiser S, Fiedler P, Mundt C, Weisbrod M. Prefrontal-cingulate activation during executive control: which comes first?Brain Res Cogn Brain Res2004;18:278-287.
63.
63. Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci2003;26:17-22.
64.
64. Webster MJ, Weickert CS, Herman MM, Kleinman JE. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res2002;15:139-150.
65.
65. Levy F, Swanson JM. Timing, space and ADHD: the dopa-mine theory revisited. Aust N Z J Psychiatry2001;35:504-511.
66.
66. Sylvester CM, Krout KE, Loewy AD. Suprachiasmatic nucleus projection to the medial prefrontal cortex: a viral transneuronal tracing study. Neuroscience2002;114:1071-1080.
67.
67. Allen GC, West JR, Chen WJ, Earnest DJ. Developmental alcohol exposure disrupts circadian regulation of BDNF in the rat suprachiasmatic nucleus. Neurotoxicol Teratol2004;26:353-358.
68.
68. Kushikata T, Fang J, Krueger JM. Brain-derived neurotrophic factor enhances spontaneous sleep in rats and rabbits. Am J Physiol1999;276:R1334-R1338.
69.
69. Taishi P, Sanchez C, Wang Y, Fang J, Harding JW, Krueger JM. Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity. Am J Physiol Regul Integr Comp Physiol2001;281:R839-R845.
70.
70. Butte NF, Treuth MS, Voigt RG, Llorente AM, Heird WC. Stimulant medications decrease energy expenditure and physical activity in children with attention-deficit/hyperactivity disorder. J Pediatr1999;135:203-207.
